USA: FDA Revises Guidance on Post marketing Studies and Clinical Trials
The US Food and Drug Administration (FDA) revised its draft guidance provides information on the implementation of section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21...